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middle-income settings: protocol for a systematic
review
Karin Diaconu1*, Yen-Fu Chen2, Semira Manaseki-Holland1*, Carole Cummins1 and Richard Lilford1,2Abstract
Background: Medical device procurement processes for low- and middle-income countries (LMICs) are a poorly
understood and researched topic. To support LMIC policy formulation in this area, international public health
organizations and research institutions issue a large body of predominantly grey literature including guidelines,
manuals and recommendations. We propose to undertake a systematic review to identify and explore the medical
device procurement methodologies suggested within this and further literature. Procurement facilitators and
barriers will be identified, and methodologies for medical device prioritization under resource constraints will be
discussed.
Methods/design: Searches of both bibliographic and grey literature will be conducted to identify documents relating
to the procurement of medical devices in LMICs. Data will be extracted according to protocol on a number of
pre-specified issues and variables. First, data relating to the specific settings described within the literature will be noted.
Second, information relating to medical device procurement methodologies will be extracted, including prioritization
of procurement under resource constraints, the use of evidence (e.g. cost-effectiveness evaluations, burden of
disease data) as well as stakeholders participating in procurement processes. Information relating to prioritization
methodologies will be extracted in the form of quotes or keywords, and analysis will include qualitative
meta-summary. Narrative synthesis will be employed to analyse data otherwise extracted. The PRISMA guidelines
for reporting will be followed.
Discussion: The current review will identify recommended medical device procurement methodologies for
LMICs. Prioritization methods for medical device acquisition will be explored. Relevant stakeholders, facilitators
and barriers will be discussed. The review is aimed at both LMIC decision makers and the international research
community and hopes to offer a first holistic conceptualization of this topic.
Keywords: Developing countries, Prioritization, Procurement, Medical devicesBackground
Medical devices and equipment are crucial for quality
health service delivery. Reports and research on low- and
middle-income countries cite a lack of basic medical
devices as well as medical equipment falling into disuse
within these settings [1,2]. This severely impairs health care
provision and also translates to lost resources and funds.
The WHO Priority Medical Devices project suggests two* Correspondence: kdd217@bham.ac.uk; s.manasekiholland@bham.ac.uk
1Public Health, Epidemiology and Statistics Unit, Department of Health and
Population Sciences, University of Birmingham, B15 2TT Edgbaston, West
Midlands, UK
Full list of author information is available at the end of the article
© 2014 Diaconu et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.potential causes for this problem [2]. First, medical device
manufacturers target high-income country economies due
to a higher potential profit. Thus, medical device supply
and equipment design are restricted to products and speci-
fications suitable for deployment settings with advanced
infrastructure and technologically knowledgeable human
resources. Second, issues around the judicious procurement
of medical devices arise for low- and middle-income coun-
tries (LMICs) [see Additional file 1: Definitions: Medical
device procurement]. Inappropriate selection of products
impedes equipment uptake and use within deployment
settings. Medical devices should be appropriate for andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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affordable for health care facilities, their staff and national
governments [2-5].
However, little is known about how medical device
procurement does or should take place within LMICs, and
processes may substantially differ from those employed in
high-income countries (HICs). Within the latter settings,
technology acquisitioning processes are guided by princi-
ples of quality care delivery and value for money to ensure
containment of rising health care costs. A diverse range of
stakeholders is involved in deliberation of potential pur-
chases: clinicians, public health commissioners, researchers
and patients. The review of clinical and cost-effectiveness
evidence as well as value-based criteria such as equity form
the basis of such deliberations [6-10]. The WHO Baseline
Country Survey on medical devices illustrates that in
contrast to HICs, LMICs undertake medical device
procurement at national rather than regional or facility level
([11] and Table 1: Author’s calculation: chi-square with 3
degrees of freedom, total sample n =162, p <0.01). The
survey fails, however, to provide more granular detail on
stakeholders involved in these processes as well as principles
pursued—e.g. is cost-effectiveness a desired feature of
potential purchases?
To guide decision makers in the procurement of medical
devices for LMICs, numerous recommendations, guidelines
and tools have been issued by international think tanks and
public health organizations. Substantial heterogeneity can
be observed in relation to these: recommendations may
focus on procurement for specific interventions or service
delivery packages, clinical areas or specialties, as well as
entire health facilities and ancillary services offered [12-14].
The WHO itself recommends medical equipment selection
for procurement take the shape of ‘availability matrices’
[15]. This involves targeting clinical areas and interventions
associated to a country’s highest burden of disease and
identifying medical equipment key for investment in or
provision of said services.
To date, no systematic review and appraisal of the litera-
ture around medical device procurement recommendations,
guidelines and research exists. We propose to undertake
such a systematic review to identify how medical deviceTable 1 Procurement of medical devices at national level in rel
Country classification Does procurement of
(Responses from WHO
Yes
Low income 25
Low-middle income 31
Upper-middle income 30
High income 17
Total 103
Author’s calculation: chi-square with 3 degrees of freedom, total sample n =162, p <procurement and prioritization within LMICs should take
place in the future, based on research which reports on
procurement and prioritization processes as well as
recommendations put forth in publicized guidelines and
similar materials. The current paper serves as a study
protocol for this exercise. We believe that a systematic
review on this topic would prove beneficial to decision
makers and procurement practitioners within LMICs by
helping identify initial core principles for equipment
purchasing. Further, we wish to explore prioritization
methodologies proposed within the literature. Under
resource constraints, prioritization is a crucial part of a
procurement process and directly informs equipment
selection. Medical device-specific prioritization criteria
will be identified, and this may inform the wider debate
on how prioritization processes are shaped and imple-
mented [16-18]. Identified principles and methodologies
will be discussed and interpreted in light of information
relating to settings described, type of medical equipment
proposed for procurement, as well as type of issuing
organization and reason for document development.
The main research question is: What methods inform
or are recommended for LMIC specific medical device
and equipment procurement? In the course of exploring
the above study question, we also expect to consider: the
evidence base used to inform medical device procurement
methods and processes and the factors impacting upon
medical device procurement and the methods proposed
for medical device prioritization.
Methods/design
Search strategy
Early scoping searches on medical device procurement
methods for LMICs revealed a large body of grey literature,
issued by international public health agencies, think tanks
or similar institutions, but very few journal articles or
research studies. It was therefore important to design
search and selection strategies to be as broad and inclusive
as possible, with no time or language restrictions. The
range of documents to be included will, however, be
restricted to freely available digitized material, partly due
to resource constraints, partly because we believe thisation to country income classification (World Bank 2014)
medical devices occur at national level?
Baseline Country Survey 2010)
No
8
7
17
27
59
0.001.
Table 2 Type of search conducted and sources searched
Search type Search sources
OVID MEDLINE search algorithm
and keyword searches
Bibliographic
databases
OVID MEDLINE, OVID Embase, Cochrane Library, CRD databases (DARE, NHS EED, HTA),
CEA Registry, LILACS, African Index Medicus, Econlit, HMIC
Keyword searches Website searches TRIP, National Guideline Clearinghouse, International Guideline Library, NHS Evidence and
Clinical Evidence (NICE), Clinical Evidence (BMJ), INAHTA, CADTH, HTAi, Web of Science,
CHE York, CHEPA, Cost Effectiveness Analysis Registry, Office of Health Economics
Organizational
databases/websites
WHO Health Technology e-documentation centre, WHO, UNDP, UNICEF, UNAIDS, WB
Group (IBRD particularly), MSF, AfDB, ADB, EBRD
National donor
agencies
DFID, USAID (including MSH), AUSAID, GIZ, BMZ, JICA, and other relevant agencies that
may be identified during the search
Grey literature
databases
ZETOC, CPCI
Contacting experts Contact with experts to identify additionally relevant literature
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would be able to access. We acknowledge this as a limita-
tion of the study; however, scoping searches indicate that
the majority of documents to be retrieved are part of the
grey literature and digitized and freely available through
the World Health Organization and ancillary institutions.
A full list of sources to be searched is provided in Table 2.
To identify relevant documents from the literature,
search terms grouped around three distinct topics will be
employed: medical devices and equipment, procurement
and LMICs. Guided by a consensus definition of medical
devices [19], the review will focus on any type of medical
device ranging from consumables (e.g. bandages, needles)
to routine medical equipment (e.g. stethoscopes, ECG
machines) and devices (e.g. condoms) as well as medicalTable 3 Example of search strategy for MEDLINE (OVID SP) up
No. Search strategy
1. device.mp. or exp “Equipment and Supplies”/
2. (device* or equipment* or suppl*).mp. [mp = title, abstract, original title
word, protocol supplementary concept, rare disease supplementary con
3. exp Technology, Radiologic/ or exp Technology Assessment, Biomedica
exp Biomedical Technology/ or technology.mp. or exp “United States O
Technology/ or exp Technology, High-Cost/ or exp Technology Transfe
Wireless Technology/ or exp Technology, Dental/ or exp Green Chemis
Sensing Technology/
4. 1 or 2 or 3
5. (procure* or purchas* or acqui* or commission* or buy*or order*).mp. [
heading word, keyword heading word, protocol supplementary concep
6. (countr* adj2 (income or poor or poverty or develop* or resource or lo
word, subject heading word, keyword heading word, protocol supplem
7. (third adj2 world).mp. [mp = title, abstract, original title, name of substa
supplementary concept, rare disease supplementary concept, unique id
8. (emerging adj2 (econom* or market*)).mp. [mp = title, abstract, original
word, protocol supplementary concept, rare disease supplementary con
9. developing country.mp. or exp Developing Countries/
10. 6 or 7 or 8 or 9
11. 4 and 5 and 10
Conducted last: 28 January 2013, 15:10 (GMT). Number of records identified: 2,297.furniture (e.g. delivery beds). Search terms will refer to
medical devices and equipment, medical supplies and
medical or biomedical technologies and will include rele-
vant subject headings. Further search terms and subject
headings include synonyms for procurement and terms
around LMICs and income levels.
An OVIDMEDLINE search string is provided in Table 3.
Where possible, keyword combinations similar to the
search string provided will be used in all sources in order
to identify the relevant material. No restrictions around
the specific type of material to be retrieved will be
employed: databases, reports, notices, presentations, con-
ference proceedings, journal articles, manuals and books
will all be reviewed provided that they are freely available
and digitized. Native language speakers will be identifiedto week 2 of January 2013
, name of substance word, subject heading word, keyword heading
cept, unique identifier]
l/ or exp Fiber Optic Technology/ or exp Educational Technology/ or
ffice of Technology Assessment”/ or exp Technology/ or exp Food
r/ or exp “National Center for Health Care Technology (U.S.)”/ or exp
try Technology/ or exp Technology, Pharmaceutical/ or exp Remote
mp = title, abstract, original title, name of substance word, subject
t, rare disease supplementary concept, unique identifier]
w* or mid*)).mp. [mp = title, abstract, original title, name of substance
entary concept, rare disease supplementary concept, unique identifier]
nce word, subject heading word, keyword heading word, protocol
entifier]
title, name of substance word, subject heading word, keyword heading
cept, unique identifier]
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limiting potential translation bias.
Selection and inclusion
All records identified in the search will then be screened
for potential inclusion into the review (see Figure 1 for a
selection algorithm). At first stage, only titles will be
considered and all documents mentioning medical devices,
either specific devices or equipment/supplies in general or
interventions likely to make use of equipment (e.g. vaccina-
tions, orthopaedic surgery) will be retained. This is to
ensure that documents are indeed focused on the topic of
interest. One researcher will undertake title review; how-
ever, a second independent researcher will check a randomAll remaining documents eligible for inclusion in review 
and undergoing data extraction provided full text 
documents are digitized and freely available
Documents retrieved through search strategy
(Retain digitized materials with abstracts available)
Selection Step 1:
Title appraisal (One reviewer)
Retain: all titles referencing medical devices
Selection Step 2:
Title appraisal (Second independent reviewer)
Random 10% check of titles per each source searched
Selection Step 3:
Abstract appraisal (One reviewer)
See Figure 2 for selection algorithm
Selection Step 4:
Abstract appraisal (Second independent reviewer)
Random 10% check of abstracts per each source searched
Selection Step 5 
(Optional: to be used when abstracts prove ambiguous)
Full-text appraisal: Use criteria for abstract review
Figure 1 Study selection algorithm. Method for study selection to
be employed by the reviewers.10% sample of documents for each of the sources searched.
Any disagreements will be resolved through discussion or
consultation with a third reviewer.
Abstracts will then be reviewed in light of four pre-
specified selection criteria or questions (Figure 2). These
are directly linked to the outcome questions to be investi-
gated and are formulated so as to retain documents
including recommendations or discussions of medical de-
vice procurement and prioritization processes, or docu-
ments clearly indicating factors which may impact upon
medical device procurement. In addition, we have chosen
to include only documents discussing processes relating
to the procurement of more than one device: this is
because we consider that any prioritization process poten-
tially employed in procurement would fundamentally rely
on the comparative assessment or evaluation of more than
one technology/product. Reviewers will, however, take
into account that documents may restrict their focus to
one device while still including a discussion on the relative
merits of similar devices: e.g. a document on the procure-
ment and pre-qualification of a particular intrauterine
contraceptive device may still be included provided that it
includes a more detailed discussion on similar devices and
their specifications [20]. Documents discussing only regu-
latory issues relating to procurement or medical device
supply have also been excluded as they are considered too
narrow in focus to provide meaningful information on the
outcome question set.
The selection questions to be used are detailed below
and have been piloted by two independent reviewers on a
sample of 20 documents retrieved from OVID MEDLINE
and the WHO E-Health Technology Documentation
Centre. The latter database has been identified in scoping
searches as including a large body of relevant material and
was therefore considered suitable for piloting. The ques-
tions were deemed appropriate for the purposes of this
study and are outlined below along with examples of doc-
uments identified in the piloting process as appropriate/
inappropriate for inclusion. These examples were made
available to reviewers for consultation during the study
selection phase of the review.
A. Is the record a guideline, recommendation or policy
document aimed at health service providers/
commissioners/managers, or does the record
include a clearly stated recommendation for
medical device procurement within low and middle
income settings?
Example of ‘yes’: World Health Organization [21]:
Procuring Single-use Injection Equipment and Safety
Boxes. The executive summary indicates that the
objective of the document is to “accompany
pharmacists, physicians, procurement staff and
programme managers through the process of
Figure 2 Abstract and full-text inclusion and exclusion criteria. Method for abstract selection to be employed by the reviewers.
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boxes of assured quality, on a national or international
market, at reasonable prices”.
Example of ‘no’: Ross et al. [22]. Study protocol:
Ethics, Economics and the Regulation and Adoption
of New Medical Devices: Case Studies in Pelvic
Floor Surgery [22]. Rejected because the methods
section of the abstract indicates this study uses
examples from a Canadian context; no link to
LMICs is stated.
B. Does the record highlight any clearly stated issues or
factors relevant to procurement or device
prioritisation for low- or middle-income settings?
Example of ‘yes’: Anderson, B. O et al. [23].
Optimisation of breast cancer management in low-
resource and middle-resource countries: executive
summary of the Breast Health Global Initiative
consensus, 2010 [23]. Abstract indicates that journal
article includes a discussion on “programme
infrastructure and capacity (including appropriate
equipment and drug acquisitions, and professional
training and accreditation).”
Example of ‘no’: Porto, J. P et al. [24]. Nosocomial
infections in a paediatric intensive care unit of a
developing country: NHSN 45(4), 475–479 [24].
Rejected because abstract does not mention
procurement or device prioritization.C. Is a class of medical devices or medical equipment
generally the subject of the record? (i.e. is the record
focusing on more than one device?)
Example of ‘yes’: Kalifa et al. [25]. Imaging in
pediatrics. Strategy and economic implications for the
Third World, Annales de Pediatrie 39(2): 67–70
[French] [25]. Abstract mentions medical imaging
equipment and provides two distinct examples:
ultrasonography and roentgenography.
Example of ‘no’: Malkin, R., Anand, V. [26]. A Novel
Phototherapy Device ©. [26]. Rejected because
abstract indicates document focuses on product
development of a single device.
D. Does the record consider issues beyond medical
device regulation/regulatory policy—i.e. is the record
not restricted to medical device regulation?
Example of ‘yes’: Kalifa et al. [25]. Imaging in pediatrics.
Strategy and economic implications for the Third
World, Annales de Pediatrie 39(2): 67–70 [French]
[25]. Abstract indicates that document content is not
restricted to device regulation, instead focusing on two
medical device classes and their use in LMICs.
Example of ‘no’: World Health Organization [27].
Medical Device Regulations: Global Overview and
Guiding Principles [27]. Rejected because document is
restricted to a discussion on global regulatory
frameworks and principles.
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detailed in Figure 2. This means that documents will be
included in the review if answers:
 A, C, D = Yes
 B, C, D = Yes
 A, B, C, D = Yes
The selection criteria will be re-evaluated as necessary
by reviewers, and any amendments to this original study
protocol will be noted in the published systematic review.
We acknowledge that abstracts may prove ambiguous,
and that reviewers may therefore wish to refer to full-text
documents at times. When this is needed, reviewers
should make use of the same four questions specified
above for study selection, and note that, a full-text review
has been carried out. A random 10% sample of abstracts
obtained from each of the sources searched will undergo
screening by a second independent reviewer, and all
disagreements will be resolved through discussion or
consultation with a third reviewer.
Data extraction
All documents which were screened and deemed eligible
will be included in the proposed study. The task of data
extraction will be split across reviewers, who will read full-
text documents to obtain data on a pre-specified list of
variables and questions (see Table 4: Data extraction tem-
plate). Similar to the selection criteria, the data extraction
template has been piloted on a random sample of 17
documents which were deemed eligible for inclusion from
OVID MEDLINE and the WHO E-Health Technology
Documentation Centre.
To address our study aims and outcome questions, data
relating to the following five domains will be extracted:
 Document identifier and characteristics: This covers
information unique to the document (e.g. authors,
year of publication, journal) as well as a categorization
of the document according to purpose of publication
(e.g. guideline, research study).
 Described setting: Information on country descriptions
will be noted where available in order to provide a
context to data extracted and further interpretation.
 Methodological data: This is the most substantial
task and covers information relating to prioritization
and procurement methodologies as well as factors
affecting procurement processes. Where explicit
prioritization methodologies are described, reviewers
will be instructed to extract quotes or keywords
describing these processes in order to allow for close
textual interpretation. Further questions require
reviewers to provide dichotomous ‘yes/no’ answers
relating to the use of evidence in procurement (e.g.use of cost-effectiveness evidence, health needs
assessments), availability of procurement policies/
frameworks (e.g. health technology management
frameworks), influence of stakeholders (e.g. which
institutions or facilities affect the process of
procurement) as well as influence of processes/
health campaigns (e.g. quality assurance, targeted
programmes or interventions). For any additional
information, reviewers wish to capture, an additional
“notes” section is provided.
 Equipment related data: Any information available
related to the equipment to be procured is captured
here: clinical area equipment is used in, equipment
specification, cost of procurement, and maintenance,
installation or decommissioning information among
others.
 Capacity building: Reviewers are asked to note any
proposed training strategies related to medical device
procurement in LMICs.
Analysis and interpretation
Two methods of data analysis will be employed for this sys-
tematic review, each corresponding to the type of data ex-
tracted. Where reviewers are tasked with extracting quotes
or keywords, relating in particular to prioritization methods
described in the literature, qualitative meta-summary was
deemed the most appropriate method for analysis [28].
Treating extracted quotes and keywords as a primary (i.e.
uninterpreted) description of phenomena that document
authors wish to report, qualitative meta-summary proposes
the grouping of topically similar data and the generation of
further abstractions aimed at describing underlying themes
and processes. This allows for a richer contextual inter-
pretation of data, something particularly valuable when
trying to generate initial theses in relation to how medical
device procurement and prioritization is viewed within
the literature.
For data otherwise extracted, i.e. dichotomous data
extracted on remaining pre-specified variables, narrative
synthesis was deemed appropriate [29]. In the first instance,
this will entail generating descriptive statistics and examining
associations between variables through the use of chi-square
(or Fisher’s exact) tests as appropriate. Associations between
the following variables may be investigated: presence of
health technology management frameworks (and actors
engaged in technology management) and use of commis-
sioning strategies for procurement, health service delivery
levels, evidence in procurement (e.g. health needs assess-
ments) as well as health facility equipment priorities and
assigned maintenance responsibilities for health care facil-
ity staff. Further explorations will focus on the disease
areas or type of equipment cited and specifications
recorded for these in addition to instructions on deploy-
ment in health facilities and human resource training
Table 4 Data extraction template
No. Question/item Tick if
applicable
Answer
(if applicable)
Example answers
below
1. Study ID + bibliographic information
2. Type of record
● Is the record a guideline/recommendation/policy document or an academic article?
● Is the document part of a greater study/document? (if so, appraise that document as well but link
information relating to evidence)
● Are the authors contactable?
3. Institution of origin and who the institution reports to
● Record institution (if this is an academic article, record university)
● Why did the institution develop the record?
● Under what remit does the institution operate? (e.g. if university was commissioned to develop record,
record how the institution commissioning the research will use the record, if specified)
4. Setting/country of origin and any information regarding the below (note if specified in record)
● Economic and development indicators: HDI level, GDP, GDP/capita, Health expenditure as % GDP, % total
government expenditure or medical device expenditure as % of health budget
● What does the disease burden look like? Is any epidemiological evidence presented?
● How is health care funded?
● What other factors related to country/countries in question are mentioned (e.g. income inequality, access
to health care, national security, infrastructure, health service infrastructure)?
5. Methodological data: Answers to be recorded to the below questions from the record considered.
1) Is prioritization of medical device purchasing/selection explicit?
a) If yes, describe the method presented in the record and further evaluate below questions.
2) Is it clear who/what institutions hold the responsibility for medical device management?
a) If yes, note the institutions and their remit (e.g. national, international).
3) Are budget impact (national, local or by facility level) or national health care/service funding policies
mentioned and if so is any relation to procurement or prioritisation made explicit?
4) Is health technology assessment mentioned?
Health technology assessment example phrases: evidence base; clinical and cost effectiveness data; HTA
appraisal systems; HTA process—i.e. timing, cost, staffing, expertise, national/international remit.
a) If yes, is it clear how the HTA evidence is integrated into the prioritisation and procurement decisions?
Describe the mechanism.
b) Is it clear who is responsible for HTA appraisal and for issuing recommendations? Who has access to the
HTA evidence? How is this disseminated?
5) Are direct care providers mentioned?
Examples of direct care providers: nurses, medics, volunteers etc.
a) If so, is it clear what their influence on purchasing/prioritisation is? (e.g. do they directly commission, do
they prefer certain suppliers)
b) Are any issues regarding staff training and ability to deliver services mentioned? (e.g. staff may not be
trained to use a particular device)
c) Is it clear how staff is involved in the maintenance of medical devices?
6) Are care pathways or clinical guidelines mentioned?
Examples of clinical guidelines: WHO guidelines for diabetes management, etc.
a) Is it clear what clinical guidelines or care pathway information was used in device selection or
prioritisation?
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Table 4 Data extraction template (Continued)
7) Is health needs assessment mentioned?
a) If yes, what are the health priorities of the population in question and how were they derived in the HNA
process?
b) Is it clear how the health needs assessment informed procurement decisions?
8) Are commissioning strategies for health services and equipment mentioned?
For example: Afghanistan’s MSH guide on “Equipment for BPHS for Health Posts” refers to a national
procurement strategy so both documents would need to be evaluated and the national procurement
strategy would form the basis for the guide assessed.
a) If yes, record what types of strategies are mentioned? (e.g. national, international)
b) If yes, what is the relation of said strategy to the current record being assessed? Does one form the basis
of the other, do they operate complementarily and is adherence to one or the other or both mandatory?
c) Follow up on the national or local strategy and undertake a record assessment.
9) Are health service delivery facilities (e.g. hospitals, health centres, mobile units) mentioned?
a) If yes, which facilities are directly mentioned?
b) If yes, is it clear which medical devices are a priority for each facility or facility level?
c) If yes, are ambient conditions of the facility necessary for device performance mentioned? (e.g. running
water, electricity availability)
d) If yes, and if a device list is present, is it clear if device purchasing was restricted to a particular class of
devices: e.g. consumables that do not require electricity, mobile devices that need little maintenance, etc.
10) Does the record mention expert advice on the device procurement/prioritisation?
a) If yes, what kind of expert would be consulted and what documentation do said experts provide to
inform device procurement/prioritisation?
11) Are particular standards regarding devices mentioned? Mentions of standardization regarding devices
could include naming specific brands, product specifications, specific suppliers, specific regulatory
nomenclatures)
12) Are any costs mentioned in the record?
a) If so, record which costs are mentioned.
13) Are execution strategies mentioned in regards to particular health campaigns? (either of national or
international importance)
Examples include: HIV/AIDS campaigns which are commissioned through UNAIDS
a) If yes, who/what institution advises on device procurement and prioritisation?
b) Is it clear what the recommendations regarding device procurement are? Note down recommendations.
14) Are more up to date versions of lists/guidelines/methods of the same record present?
a) If yes, appraise newer record versions as well.
15) Is evidence of evaluation strategies regarding procurement lists, guides, methods present?
a) What evaluation strategies are mentioned?
b) Who undertakes said evaluations?
c) Is it clear what evidence is being used to inform evaluations?
6. Equipment related data: Answers to be recorded to the below questions.
1) What are the main categories of equipment included in record?
a) Renewable supplies
b) Surgical supplies
c) Condition specific
d) Record the equipment categories mentioned.
2) How detailed is the equipment specification? (i.e. are measurements mentioned; is a description
provided;)
3) How many distinct products are mentioned?
4) Is a mix of devices mentioned and is it clear if certain devices are complementary (i.e. they need to be
used in conjunction with one another)?
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Table 4 Data extraction template (Continued)
5) Does the list mention how many items of one product to purchase?
6) Are any national/regional device coverage targets set? (i.e. how many devices/institution/region
7) Is any cost data present and if so, note down what cost data is available.
8) Is any information on installation available and if so, note what recommendations are given.
9) Is any information on maintenance available and if so, note what recommendations are given.
10) Is any information on necessary ambient conditions supplied and if so, note what said conditions are.
(i.e. “needs constant electricity supply”)
11). Is any recommendation regarding device disposal given and if so note what said recommendation is.
7. Capacity building: Answers to be recorded to the below questions.
1) Does the record outline any strategies for training people in medical device purchasing or medical device
management?
a. If yes, record what said strategies are.
8. Notes
Recording of any additional information that seems of relevance.
Example: WHO Priority Medical Devices frequently refers to diagnostic coding systems and disability
classification systems.
Provided as Excel spreadsheet to reviewers. Data extraction template provided to reviewers.
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The influence of publication year issuing organization and
reason for document development on details associated to
the above variables may also be explored. Documents may
also be grouped according to their type (e.g. research studies,
guidelines) to highlight potential differences in reporting on
procurement or prioritization processes. Capacity building
strategies related to procurement will be discussed. Mind-
maps showcasing associations may be created to provide
visual representations.
Reporting
For reporting purposes, we will follow the PRISMA state-
ment for systematic reviews and refer readers to this proto-
col for further clarifications [30]. We expect that we will not
be able to report on all items in the statement, e.g. relating
to risk of bias within or across studies (items 12, 15, 19, 22)
or to quantitative outcomes, synthesis of results or add-
itional subgroup analyses (items 13, 20, 21). Outcomes will
be discussed as aforementioned through the use of qualita-
tive meta-summary or narrative synthesis. Registration with
PROSPERO is not appropriate in the case of this review, as
it does not concern itself with a clinical intervention.
Discussion
It is unclear how medical device procurement and
prioritization take place within LMICs. Internationally pro-
posed guidelines, recommendations or reports—whether
developed by public health agencies or research institutions
—are routinely issued to counsel LMICs on this topic and
may impact upon their national policy formulation. It is
therefore germane to understand the procurement/
prioritization methodologies proposed within this literature.The aims of this systematic review are to identify said
methodologies, explore the factors reported as affecting
procurement practices in LMICs and create an initial
framework for how medical device prioritization and
procurement should be designed and conceived in
resource-constrained settings.
We acknowledge several limitations of the proposed en-
deavour. First, we note the difficulty associated with
undertaking a first-line review on a topic associated with
methodologically diverse literature. We expect that docu-
ments reviewed will range from procurement notices and
emergency medical device lists to procurement manuals
or research studies on medical device prioritization. As
little prior evaluative literature on this topic exists and as
heterogeneous priority setting criteria are suggested to
be equally legitimate [31], we are reluctant to quality ap-
praise studies we include in the review or limit inclusion
to only one type of study which may advance a particu-
lar prioritization methodology. This may imply more la-
borious and complex data analysis and may furthermore
undermine the validity of any findings. Reviewing the
literature obtained from such diverse sources, however, is
greatly beneficial for hypothesis generation as it allows for
consideration of multiple viewpoints and identification of
minutiae associated with medical device prioritization and
procurement for LMICs. In particular, it will allow for the
mapping of all the different types of literature and poten-
tial methodological differences on this topic.
Second, we make no concerted effort to identify or
include national policy documents relating to medical
devices in this review. This is because the focus of the re-
view is normative and concerns itself with the identification
of procurement and prioritization methodologies within
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lines as well as research studies. We are thus interested
in answering the question of how procurement and
prioritization should take place considering current
research and guideline materials. We acknowledge that
national policies may in fact employ different procurement
or prioritization methodologies, which we may fail to iden-
tify here and thus, encourage further inquiries into both the
policy literature as well as the empirical implementation
literature beyond. Should materials meet inclusion criteria,
they will be selected for review. It is beyond the scope of
this review to undertake an appraisal of all internationally
available policy documents. Indeed, we caution that a sys-
tematic review of policies alone may fail to identify macro-
level issues and themes relating primarily to international
decision making paradigms (e.g. paradigms of international
donor organizations or funding bodies supporting LMIC
procurement). An inquiry into the normative bases of med-
ical device procurement for LMICs is valuable in the initial
exploration, and identification of issues, paradigms and
processes is to be considered by decision makers. Review
findings may provide a starting point to future policy
analyses or research endeavours within this field.
Furthermore, the review may be limited in scope, as it is
not designed to identify and include prioritization
methodologies referring to entire intervention packages
rather than devices or equipment. To make sure that
applicable methodologies are not discounted, reviewers
will consult experts in international health to identify any
such relevant methodologies and discuss the findings of
the current review in light of these.
An accurate understanding of medical device procure-
ment and prioritization methods is of particular importance
in resource-constrained settings with limited financial
capabilities, human resource skills and health infrastruc-
ture. The findings of this systematic review will provide
initial hypotheses as to what factors and stakeholders affect
these processes and may aid in the formulation of a quality
assurance framework able to provide LMIC decision
makers with a rounded conceptualization of the topic.Additional file
Additional file 1: Definitions: Medical device procurement. Definitions
for medical device/equipment procurement and prioritization within
procurement cycles are provided.Abbreviations
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